These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38251842)
61. Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia. Wang X; Bi H; Liu L; Liu Y; Yin L; Yao J; Yu J; Tao W; Wei Y; Li Y; Yin L; Mu H; Du Y; Zhou Z Platelets; 2023 Dec; 34(1):2271568. PubMed ID: 37941414 [TBL] [Abstract][Full Text] [Related]
62. Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia. Gabe C; Liu Y; Duncan J; St John M; Lucier KJ; Kimmel D; Kelton JG; Arnold DM Platelets; 2023 Dec; 34(1):2144194. PubMed ID: 36458562 [TBL] [Abstract][Full Text] [Related]
63. The predictive value of regulatory T cells on glucocorticoid sensitivity in patients with immune thrombocytopenia: a multicentre, prospective clinical study. Li L; Zhao Y; Tong X; Li Y; Huang L; Hui Y; Mao X; Wei J; Shang Z; Wang L; Xiang H; Guo J; Chang W; Zhang X; Liu L; Gao K; Zhang D Br J Haematol; 2021 May; 193(3):619-627. PubMed ID: 33690890 [TBL] [Abstract][Full Text] [Related]
64. A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia. Al-Samkari H; Rosovsky RP; Karp Leaf RS; Smith DB; Goodarzi K; Fogerty AE; Sykes DB; Kuter DJ Blood Adv; 2020 Jan; 4(1):9-18. PubMed ID: 31891657 [TBL] [Abstract][Full Text] [Related]
65. The prediction value of Treg cell subtype alterations for glucocorticoid treatment in newly diagnosed primary immune thrombocytopenia patients. Cheng L; Liu C; Li F; Wu B; Min Z; Chen P; Zhan Y; Ke Y; Hua F; Yuan L; Sun L; Chen H; Ji L; Cheng Y Thromb Res; 2019 Sep; 181():10-16. PubMed ID: 31323447 [TBL] [Abstract][Full Text] [Related]
66. Expression of CD11a in lymphocyte subpopulation in immune thrombocytopenia. Liu YX; Zhang F; Yao QM; Yuan T; Xu J; Zhu XJ Int J Clin Exp Pathol; 2015; 8(12):15642-51. PubMed ID: 26884833 [TBL] [Abstract][Full Text] [Related]
67. Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP. Weitz IC; Liebman HA Br J Haematol; 2023 Oct; 203(1):96-100. PubMed ID: 37735550 [TBL] [Abstract][Full Text] [Related]
68. Glycocalicin in the diagnosis and management of immune thrombocytopenia. Steffan A; Pradella P; Cordiano I; Girolami A; De Marco L; Fabris F Eur J Haematol; 1998 Aug; 61(2):77-83. PubMed ID: 9714518 [TBL] [Abstract][Full Text] [Related]
69. The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test. Vrbensky JR; Moore JE; Arnold DM; Smith JW; Kelton JG; Nazy I J Thromb Haemost; 2019 May; 17(5):787-794. PubMed ID: 30801909 [TBL] [Abstract][Full Text] [Related]
70. Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura. Li J; Wang Z; Hu S; Zhao X; Cao L Immunol Lett; 2013; 154(1-2):42-8. PubMed ID: 23994430 [TBL] [Abstract][Full Text] [Related]
71. Persistent neonatal thrombocytopenia can be caused by IgA antiplatelet antibodies in breast milk of immune thrombocytopenic mothers. Hauschner H; Rosenberg N; Seligsohn U; Mendelsohn R; Simmonds A; Shiff Y; Schachter Y; Aviner S; Sharon N Blood; 2015 Jul; 126(5):661-4. PubMed ID: 26077397 [TBL] [Abstract][Full Text] [Related]
72. The pathogenesis of chronic immune thrombocytopenic purpura. McMillan R Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470 [TBL] [Abstract][Full Text] [Related]
73. Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction Han P; Yu T; Hou Y; Zhao Y; Liu Y; Sun Y; Wang H; Xu P; Li G; Sun T; Hu X; Liu X; Li L; Peng J; Zhou H; Hou M Front Immunol; 2021; 12():630693. PubMed ID: 33679776 [TBL] [Abstract][Full Text] [Related]
74. Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia. Li N; Mahamad S; Parpia S; Iorio A; Foroutan F; Heddle NM; Hsia CC; Sholzberg M; Rimmer E; Shivakumar S; Sun HL; Refaei M; Hamm C; Arnold DM J Thromb Haemost; 2022 Dec; 20(12):2988-2997. PubMed ID: 36121734 [TBL] [Abstract][Full Text] [Related]
75. Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypes. Oka S; Ono K; Nohgawa M Int J Hematol; 2020 Jun; 111(6):771-778. PubMed ID: 32162096 [TBL] [Abstract][Full Text] [Related]
76. The short-term predictive value of CD4 Liu H; Liu X; Zhang G; Wang J; Naren D; Xie S; Li Y; Nie D; Li Z; Ma L Thromb Res; 2022 Oct; 218():157-168. PubMed ID: 36054980 [TBL] [Abstract][Full Text] [Related]
77. Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial. Feng FE; Feng R; Wang M; Zhang JM; Jiang H; Jiang Q; Lu J; Liu H; Peng J; Hou M; Shen JL; Wang JW; Xu LP; Liu KY; Huang XJ; Zhang XH Lancet Haematol; 2017 Oct; 4(10):e487-e496. PubMed ID: 28917657 [TBL] [Abstract][Full Text] [Related]
78. Increase of C3a is Associated with Hemorrhagic Propensity in Patients with Immune Thrombocytopenia. Ge J; Wang L; Li J; Hu Y; Xu Q; Chen Y; Hou R; Ruan M; Xia R; Zeng Q Clin Lab; 2017 Apr; 63(4):765-771. PubMed ID: 28397467 [TBL] [Abstract][Full Text] [Related]
79. [Expression and Significance of PD-1 and ICOS in Patients with Primary Immune Thrombocytopenia]. Fu Z; Qu W; Shao ZH; Wang HQ; Xing LM; Dong XF; Liu ZY; Li XN; Zhang Y; Ding SX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1170-1175. PubMed ID: 35981379 [TBL] [Abstract][Full Text] [Related]
80. Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia. Fabris F; Steffan A; Cordiano I; Borzini P; Luzzatto G; Randi ML; Girolami A Eur J Haematol; 1994 Oct; 53(4):232-6. PubMed ID: 7957808 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]